Literature DB >> 22728250

Altered expression profiles of microRNAs upon arsenic exposure of human umbilical vein endothelial cells.

Xinna Li1, Yanfen Shi1, Yudan Wei2, Xiaotu Ma3, Yulin Li1, Ronggui Li4.   

Abstract

Recent studies in our laboratory indicated that arsenite at 20μM significantly induces the apoptosis of HUVECs. In this study we analyzed miRNAs expression profiles upon arsenic exposure of these cells to explore the molecular mechanisms of arsenic-induced vascular toxicity. The expression of miRNAs was examined by Exiqon miRCURY™ LNA microRNA chips. We found that 85 miRNAs were up-regulated and 52 were down-regulated by arsenic treatment as compared to the control group. The expression of altered miRNAs was validated by quantitative reverse-transcription PCR (qRT-PCR). A number of DNA motifs were identified in the promoters of the perturbed miRNAs by promoter analysis using MEME software. Analysis of cellular functions by using DAVID Bioinformatics Resources revealed that phosphoproteins and genes involved in alternative splicing are among the top categories targeted by both up- and down-regulated miRNAs. In conclusion, the results show that the alteration of miRNAs expression might play crucial roles in arsenic-induced vascular injury.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728250     DOI: 10.1016/j.etap.2012.05.003

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  10 in total

1.  Arsenic exposure during embryonic development alters the expression of the long noncoding RNA growth arrest specific-5 (Gas5) in a sex-dependent manner.

Authors:  Kevin K Caldwell; Alexander Hafez; Elizabeth Solomon; Matthew Cunningham; Andrea M Allan
Journal:  Neurotoxicol Teratol       Date:  2017-11-11       Impact factor: 3.763

2.  Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway.

Authors:  Horacio Gonzalez; Carolina Lema; Robert A Kirken; Rosa A Maldonado; Armando Varela-Ramirez; Renato J Aguilera
Journal:  Clin Cancer Drugs       Date:  2015

3.  Arsenic responsive microRNAs in vivo and their potential involvement in arsenic-induced oxidative stress.

Authors:  Xuefeng Ren; Daniel P Gaile; Zhihong Gong; Wenting Qiu; Yichen Ge; Chuanwu Zhang; Chenping Huang; Hongtao Yan; James R Olson; Terrance J Kavanagh; Hongmei Wu
Journal:  Toxicol Appl Pharmacol       Date:  2015-01-24       Impact factor: 4.219

Review 4.  Analysis of the transcriptome in molecular epidemiology studies.

Authors:  Cliona M McHale; Luoping Zhang; Reuben Thomas; Martyn T Smith
Journal:  Environ Mol Mutagen       Date:  2013-08-01       Impact factor: 3.216

5.  Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood.

Authors:  Julia E Rager; Kathryn A Bailey; Lisa Smeester; Sloane K Miller; Joel S Parker; Jessica E Laine; Zuzana Drobná; Jenna Currier; Christelle Douillet; Andrew F Olshan; Marisela Rubio-Andrade; Miroslav Stýblo; Gonzalo García-Vargas; Rebecca C Fry
Journal:  Environ Mol Mutagen       Date:  2013-12-10       Impact factor: 3.216

Review 6.  MiR-21: an environmental driver of malignant melanoma?

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2015-06-27       Impact factor: 5.531

Review 7.  MicroRNAs as potential signatures of environmental exposure or effect: a systematic review.

Authors:  Karen Vrijens; Valentina Bollati; Tim S Nawrot
Journal:  Environ Health Perspect       Date:  2015-01-16       Impact factor: 9.031

Review 8.  Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?

Authors:  Rowan Beck; Miroslav Styblo; Praveen Sethupathy
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

Review 9.  Arsenic-induced changes in miRNA expression in cancer and other diseases.

Authors:  Ana P Ferragut Cardoso; Karen T Udoh; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2020-10-28       Impact factor: 4.219

10.  Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers.

Authors:  Andrea Polo; Silvia Marchese; Giuseppina De Petro; Maurizio Montella; Gennaro Ciliberto; Alfredo Budillon; Susan Costantini
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.